Home » Prices » NASDAQ:CRVS

Corvus Pharmaceuticals, Inc. stock price

Today's NASDAQ:CRVS chart, history & news

Price:
4.03 USD
Change:
+0.13 (3.33%)
Key Stats
Price open 3.91
Previous close 3.9
Market cap 113.09M
Volume 61.94K
Day high 4.08
Day low 3.91
Year high 5.98
Year low 1.74
Year to date change -15.91%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The company focuses on disabling cancer’s ability to subvert immune attack by inhibiting adenosine in the tumor microenvironment and by blocking its production by tumors. Its product pipeline includes Adenosine A2A Receptor Antagonist CPI-444, Adenosine Production Inhibitor Anti-CD73, Adenosine A2B Receptor Antagonist, ITK Inhibitor, and Myeloid Cell Suppression. The company was founded by Richard A. Miller, Peter A. Thompson, and Joseph J. Buggy on January 27, 2014 and is headquartered in Burlingame, CA.

Company information

Company name
Corvus Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Major
Employees
53
CEO
Richard A. Miller
Address
863 Mitten Road, Burlingame, CA, 94010
Country
United States
Contact information
1.650.900.4520
Website
http://www.corvuspharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.